Published: May 29, 2026
Written by Klarity Editorial Team
Published: May 29, 2026

If you’re struggling with premenstrual dysphoric disorder (PMDD), you’ve probably heard conflicting information about whether you can get treatment through telehealth. With all the recent news about DEA restrictions and in-person requirements, it’s easy to feel confused about your options.
Here’s the good news: You can absolutely receive PMDD treatment online in 2025—and no, you don’t need an in-person visit first.
Let me clear up the confusion and explain exactly how telehealth prescribing works for PMDD medications, what the current regulations actually say, and how you can access safe, legitimate care from the comfort of your home.
You may have seen headlines about the DEA cracking down on telehealth prescriptions or requiring in-person visits. This has understandably scared many people away from seeking online mental health care.
Here’s what those headlines aren’t telling you: The DEA restrictions apply exclusively to controlled substances—medications like Adderall, Xanax, and opioids that have a high potential for abuse.
The most commonly prescribed medications for PMDD—Zoloft (sertraline) and Prozac (fluoxetine)—are not controlled substances. They’re SSRIs (selective serotonin reuptake inhibitors), which means they fall under a completely different regulatory category.
There is no federal requirement for an in-person examination before a licensed healthcare provider can prescribe Zoloft or Prozac via telehealth. These medications have been prescribable through telehealth platforms both before and during the COVID-19 pandemic, and nothing about that has changed in 2025.
The regulations that govern controlled substance prescribing—including the Ryan Haight Act and recent DEA temporary extensions—simply don’t apply to SSRI medications used for PMDD treatment.
Getting PMDD treatment online is straightforward, safe, and completely legal when done through a legitimate telehealth platform like Klarity Health.
Initial Consultation: You’ll meet with a licensed psychiatric provider (psychiatrist, psychiatric nurse practitioner, or physician assistant) via secure video or audio-visual appointment. During this visit, your provider will:
Prescription: If your provider determines that medication is the right choice, they can electronically send a prescription for Zoloft, Prozac, or another appropriate SSRI directly to your preferred pharmacy—often the same day.
Follow-up Care: Your provider will schedule follow-up appointments (usually via telehealth) to monitor your response to treatment, adjust dosages if needed, and ensure you’re experiencing relief without problematic side effects.
For telehealth PMDD prescribing to be legal and appropriate, three things must be in place:
Klarity Health ensures all three requirements are met. Our providers are licensed in multiple states, use secure HIPAA-compliant technology, and follow clinical best practices for diagnosing and treating PMDD.
While federal law doesn’t restrict telehealth prescribing of SSRIs, state regulations can vary—particularly when it comes to which types of providers can prescribe independently.
California and New York: Nurse practitioners (NPs) with sufficient experience can prescribe medications like Zoloft and Prozac independently, without physician oversight. In California, ‘103 NPs’ with three or more years of experience can practice autonomously in group settings. In New York, NPs with more than 3,600 hours of experience (approximately two years) don’t need a written collaborative agreement.
Texas and Florida: These states require nurse practitioners to work under collaborative agreements with physicians. This doesn’t mean you can’t get care from an NP—it simply means the NP has a formal relationship with a supervising physician who oversees their prescribing authority. For you as a patient, this actually adds an extra layer of safety and oversight.
At Klarity Health, we ensure all our providers operate within their state’s legal requirements. In collaborative states, our NPs work closely with supervising physicians to deliver safe, high-quality care.
Some states require providers to check Prescription Drug Monitoring Programs (PDMPs) before prescribing certain medications. However, these requirements apply only to controlled substances like benzodiazepines or stimulants.
SSRIs used for PMDD are not controlled substances, so PMP checks are not required in any state for medications like Zoloft or Prozac. This streamlines the prescribing process while maintaining safety.
Just because something is convenient doesn’t mean it should compromise on safety. Legitimate telehealth platforms take patient safety extremely seriously—in some ways, even more seriously than traditional in-person care.
Because PMDD is strongly associated with depression and increased suicide risk, responsible telehealth providers conduct thorough mental health screenings before prescribing treatment. This typically includes:
If a provider identifies active, high-risk suicidal ideation, they may determine that in-person crisis care is more appropriate than starting medication via telehealth alone. This is a feature, not a bug—it demonstrates that the platform prioritizes patient safety over convenience.
PMDD treatment isn’t ‘prescribe and forget.’ Your provider should:
Klarity Health offers transparent, affordable follow-up care to ensure your treatment continues to work effectively. We also accept both insurance and self-pay options, making ongoing care accessible regardless of your coverage situation.
| Factor | Telehealth (Klarity Health) | Traditional In-Person |
|---|---|---|
| Initial Wait Time | Often same-day or next-day appointments | 2-4 weeks on average for psychiatry |
| Appointment Flexibility | Evening and weekend options widely available | Limited to office hours |
| Geographic Access | Available anywhere in your state | Limited to providers in your area |
| Prescription Access | Same medications (Zoloft, Prozac, etc.) | Same medications |
| Provider Licensing | Licensed in your state | Licensed in your state |
| Cost Transparency | Clear upfront pricing, insurance accepted | Often unclear until after visit |
| Follow-up Convenience | Video appointments from home | Requires travel and time off |
You may have heard that certain telehealth prescribing rules expire at the end of 2025. This is true—but only for controlled substances.
The DEA’s temporary extension that allows prescribing controlled substances without an initial in-person visit does expire on December 31, 2025. The agency is working on a ‘Special Registration’ rule for controlled substance telehealth prescribing in 2026.
This has zero impact on PMDD treatment with SSRIs. The ability to prescribe Zoloft and Prozac via telehealth is not temporary, not dependent on COVID emergency rules, and not changing on January 1, 2026.
Your access to online PMDD treatment will continue unchanged, regardless of what happens with controlled substance regulations.
If you’re ready to explore treatment options for PMDD, here’s what to do:
Verify Your Location: Make sure the telehealth platform you choose has providers licensed in your state. Klarity Health operates in multiple states with licensed psychiatric providers ready to help.
Gather Your Information: Before your appointment, think about:
Schedule an Evaluation: Book a consultation with a licensed psychiatric provider who specializes in women’s mental health and PMDD.
Be Honest and Thorough: The more information you share with your provider, the better they can tailor treatment to your specific needs. Don’t minimize your symptoms or hold back concerns about medication.
Follow Through: If prescribed medication, take it as directed and keep your follow-up appointments. SSRIs typically take 2-4 weeks to show full effects, so patience and consistent communication with your provider are key.
You have every legal right to access PMDD treatment through telehealth in 2025. The regulations are clear: non-controlled SSRI medications can be prescribed via secure video appointments by licensed providers without any in-person requirement.
Don’t let misinformation or outdated concerns keep you from getting the help you need. PMDD is a real, debilitating condition that significantly impacts quality of life—and effective treatment is available.
At Klarity Health, we’re committed to making mental healthcare accessible, affordable, and convenient. Our providers have availability when you need it, our pricing is transparent whether you use insurance or pay out of pocket, and we ensure every aspect of your care meets both regulatory requirements and clinical best practices.
You deserve relief from PMDD symptoms. You deserve care that fits your schedule and your life. And you absolutely have the legal right to access that care through telehealth.
Ready to take the next step? Schedule a consultation with a Klarity Health provider today and start your journey toward feeling like yourself again—every day of the month, not just the days after your period.
AuraMD. (2024). ‘Telemedicine Prescribing Laws.’ Retrieved from https://www.auramd.com
Drug Enforcement Administration. (2024). ‘Telemedicine Prescribing of Controlled Substances.’ Retrieved from https://www.dea.gov
JD Supra. (2025). ‘DEA Extends COVID-19 Telemedicine Flexibilities Through December 31, 2025.’ Retrieved from https://www.jdsupra.com
Mental Health America. (2024). ‘Telehealth Policy Update: Fourth Extension.’ Retrieved from https://www.mha.org
PRMS. (2024). ‘Ryan Haight Act and Telemedicine.’ Retrieved from https://www.prms.com
This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider for diagnosis and treatment recommendations specific to your situation.
Find the right provider for your needs — select your state to find expert care near you.